The Anti-Dengue Virus Peptide DV2 inhibits Zika Virus both in vitro and in vivo (2023)
- Authors:
- USP affiliated authors: FERNANDES, ANDREA BALAN - ICB ; FERREIRA, LUIS CARLOS DE SOUZA - ICB ; AMARANTE, MARIA FERNANDA DE CASTRO - ICB ; PEREIRA, SAMUEL SANTOS - ICB ; SANTOS, LUCAS SOUZA DOS - ICB ; CARVALHO, ALEXIA ADRIANNE VENCESLAU BRITO - ICB ; PEREIRA, LENNON RAMOS - ICB
- Unidade: ICB
- DOI: 10.3390/v15040839
- Subjects: MICROBIOLOGIA; PEPTÍDEOS; ZIKA VÍRUS; DENGUE ANIMAL; ANTIVIRAIS; FLAVIVIRUS; VÍRUS DA DENGUE; MODELOS ANIMAIS DE DOENÇAS; CAMUNDONGOS; INFECÇÕES POR VÍRUS DE RNA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
AMARANTE, Maria Fernanda de Castro et al. The Anti-Dengue Virus Peptide DV2 inhibits Zika Virus both in vitro and in vivo. Viruses, v. 15, n. 4, p. 1-11, 2023Tradução . . Disponível em: https://doi.org/10.3390/v15040839. Acesso em: 31 mar. 2026. -
APA
Amarante, M. F. de C., Pereira, S. S., Pereira, L. R., Santos, L. S., Carvalho, A. A. V., Martins, E. G., et al. (2023). The Anti-Dengue Virus Peptide DV2 inhibits Zika Virus both in vitro and in vivo. Viruses, 15( 4), 1-11. doi:10.3390/v15040839 -
NLM
Amarante MF de C, Pereira SS, Pereira LR, Santos LS, Carvalho AAV, Martins EG, Balan A, Ferreira LC de S. The Anti-Dengue Virus Peptide DV2 inhibits Zika Virus both in vitro and in vivo [Internet]. Viruses. 2023 ; 15( 4): 1-11.[citado 2026 mar. 31 ] Available from: https://doi.org/10.3390/v15040839 -
Vancouver
Amarante MF de C, Pereira SS, Pereira LR, Santos LS, Carvalho AAV, Martins EG, Balan A, Ferreira LC de S. The Anti-Dengue Virus Peptide DV2 inhibits Zika Virus both in vitro and in vivo [Internet]. Viruses. 2023 ; 15( 4): 1-11.[citado 2026 mar. 31 ] Available from: https://doi.org/10.3390/v15040839 - The third vaccine dose significantly reduces susceptibility to the B.1.1.529 (Omicron) SARS-CoV-2 variant
- Transcutaneous administration of dengue vaccines
- Nanovaccine based on self-assembling nonstructural protein 1 boosts antibody responses to Zika virus
- Association of high pressure and alkaline condition for solubilization of inclusion bodies and refolding of the NS1 protein from zika virus
- TLR2 axis on peripheral blood mononuclear cells regulates inflammatory responses to non-infectious immature dengue virus particles
- Enhanced immune responses and protective immunity to Zika vrus induced by a DNA vaccine encoding a chimeric NS1 fused wth tpe 1 Herpes vrus gD protein
- Layer-by-Layer assembly of polymeric nanoparticles with heparin-RBD complexes as an adjuvant for SARS-Cov-2 protein-based vaccines
- Protective immunity to Dengue virus induced by DNA vaccines encoding nonstructural proteins in a lethal challenge immunocompetent mouse model
- Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells
- Specificity of NS1-based immunochromatographic tests for dengue virus with regard to the Zika virus protein
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
